Literature DB >> 15959552

Pleurodesis as a palliative treatment of advanced lung cancer with malignant pleural effusion.

Ismail A Mourad1, Abdel Rahman M Abdel Rahman, Sherif A Aziz, Nagi M Saber, Fouad A Fouad.   

Abstract

PURPOSE: This study was conducted to evaluate the success rate of management of advanced. Lung cancer patients with malignant pleural effusion comparing talc powder with tetracycline for pleurodesis. PATIENTS AND METHODS: We report 60 patients with lung cancer associated with malignant pleural effusion treated in the department of surgery NCI, Cairo University, between January. 1998 and February, 2003. Patients were Divided Into Three Groups: Group I: Pleurodesis using tetracycline (20 patients). Group II: Pleurodesis using talc slurry (20 patients). Group III: Pleurodesis using talc insufflation (20 patients). Good response to pleurodesis is defined as no pleural fluid re-accumulation or minimal pleural fluid re-accumulation not causing symptoms or requiring further aspiration for one month.
RESULTS: There were 34 males and 26 females, mean age was 54 years with range of 42-66 years, right sided effusion was present in 32 patients (53%) and left sided in 28 patients (47%). Pathological subtypes were adenocarcinoma in 32 patients, squamous cell carcinoma in 18 and undifferentiated carcinoma in 10 patients. In group I, 12 patients (60%) showed good response to intrapleural tetracycline, 15 patients (75%) responded in group II, while 17 patients (85%) showed good response in group III. Post pleurodesis complications included, fever, chest pain and empyema.
CONCLUSION: It is concluded from this study that thoracoscopic talc insufflation was an effective, easy and low cost method for producing pleurodesis in patients with recurrent malignant pleural effusion and proved to be better than talc slurry and tetracycline.

Entities:  

Year:  2004        PMID: 15959552

Source DB:  PubMed          Journal:  J Egypt Natl Canc Inst        ISSN: 1110-0362


  2 in total

1.  Treatment for resistant subphrenic abscess by combined intracavitary doxycycline and cyanoacrylate injection.

Authors:  Hussein Okasha; Mohammed Mahmoud
Journal:  J Adv Res       Date:  2013-08-17       Impact factor: 10.479

2.  Pleurodesis by erythromycin, tetracycline, Aerosil™ 200, and erythromycin plus Aerosil™ 200 in a rat model: a preliminary study.

Authors:  Shahryar Hashemzadeh; Khosrow Hashemzadeh; Kamran Mamaghani; Elnaz Ansari; Raheleh Aligholipour; Samad Ej Golzari; Kamyar Ghabili
Journal:  Daru       Date:  2012-11-26       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.